Characterization of the intraspecies chimeric mouse brain at embryonic day 12.5
Cell Transplantation · 2025
DOI: 10.1177/09636897251384571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Transplantation, 2025. Verfasst von Phoebe Strell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Medical School, University of Minnesota, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Brain, Chimera. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Incidence of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis have increased dramatically as life expectancy has risen year-over-year, and can lead to neurologic changes. Neurological changes within the central nervous system, specifically the brain, include cell loss and deterioration that impact motor function, memory, executive function, and mood. Available treatments are limited and often only address symptomatic manifestations of the disease rather than disease progression. Cell transplantation therapy has shown promise for treating neurodegenerative diseases, but a source of autologous cells is required. Blastocyst complementation provides an innovative method for generating autologous neural cells. By injecting mouse induced pluripotent stem cells into a wild type mouse blastocyst, we generated a chimeric mouse brain derived of both donor and host neuronal and non-neuronal cells. At embryonic day 12.5 (E12.5), automated image analysis of mouse-mouse chimeric brains showed the presence of GFP-labeled donor-derived dopaminergic and serotonergic neuronal precursors. GFP-labeled donor-derived cholinergic precursor neurons and non-neuronal microglia-like and macrophage-like cells were also observed using more conventional imaging analysis software. This work demonstrates that the generation of mouse-mouse chimeric neural cells is possible; and that characterization of early neuronal and non-neuronal precursors provides a first step toward utilizing these cells for cell transplantation therapies for neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Medical School, University of Minnesota, Minneapolis, MN, USA.
- Stem Cell Institute, Medical School, University of Minnesota, Minneapolis, MN, USA.
- Department of Veterinary and Biomedical Sciences, University of Minnesota, Saint Paul, MN, USA.
- Graduate Program in Neuroscience, Medical School, University of Minnesota, Minneapolis, MN, USA.
- Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
- Mouse Genetics Laboratory, University of Minnesota, Minneapolis, MN, USA.
ORCID-Profile: Phoebe Strell, Anala Shetty, Walter C Low
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- NIA NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute on Aging
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Strell, P., Waldron, M. A., Johnson, S. T., Shetty, A., Crane, A. T., You, Y., Steer, C. J., & Low, W. C. (2025). Characterization of the intraspecies chimeric mouse brain at embryonic day 12.5. Cell Transplantation. https://doi.org/10.1177/09636897251384571
Vancouver
Strell P, Waldron MA, Johnson ST, Shetty A, Crane AT, You Y, et al. Characterization of the intraspecies chimeric mouse brain at embryonic day 12.5. Cell Transplantation. 2025. doi:10.1177/09636897251384571
BibTeX
@article{Strell2025,
author = {Strell, Phoebe and Waldron, Madison A and Johnson, Sether T and Shetty, Anala and Crane, Andrew T and You, Yun and Steer, Clifford J and Low, Walter C},
title = {Characterization of the intraspecies chimeric mouse brain at embryonic day 12.5},
journal = {Cell Transplantation},
year = {2025},
doi = {10.1177/09636897251384571}
}
EUVIMED